Norinchukin Bank’s Alexion Pharmaceuticals ALXN Stock Holding History

Norinchukin Bank’s Portfolio ALXN Stock Details ALXN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-20,826	Closed	-$3.83M	–	550
2021 Q2	$3.83M	Buy	20,826 +455	+2%	+$78.1K	0.06%	175
2021 Q1	$3.12M	Buy	20,371 +979	+5%	+$151K	0.04%	196
2020 Q4	$3.03M	Sell	19,392 -118	-0.6%	-$15.2K	0.04%	180
2020 Q3	$2.23M	Buy	19,510 +447	+2%	+$48.2K	0.04%	209
2020 Q2	$2.14M	Sell	19,063 -202	-1%	-$21.4K	0.04%	201
2020 Q1	$1.73M	Sell	19,265 -10,705	-36%	-$1.05M	0.03%	208
2019 Q4	$3.24M	Sell	29,970 -3,087	-9%	-$330K	0.04%	238
2019 Q3	$3.24M	Buy	33,057 +814	+3%	+$91.8K	0.05%	249
2019 Q2	$4.22M	Sell	32,243 -10,809	-25%	-$1.39M	0.06%	187
2019 Q1	$5.82M	Buy	43,052 +1,548	+4%	+$192K	0.07%	175
2018 Q4	$4.04M	Buy	41,504 +12,841	+45%	+$1.52M	0.06%	205
2018 Q3	$3.98M	Buy	28,663 +3,453	+14%	+$433K	0.05%	187
2018 Q2	$3.13M	Buy	25,210 +4,898	+24%	+$572K	0.05%	192
2018 Q1	$2.26M	Buy	20,312 +2,450	+14%	+$293K	0.04%	216
2017 Q4	$2.14M	Buy	17,862 +1,249	+8%	+$152K	0.04%	220
2017 Q3	$2.33M	Buy	16,613 +1,029	+7%	+$140K	0.05%	231
2017 Q2	$1.9M	Buy	15,584 +989	+7%	+$115K	0.04%	259
2017 Q1	$1.77M	Buy	14,595 +992	+7%	+$128K	0.04%	253
2016 Q4	$1.66M	Buy	13,603 +1,597	+13%	+$195K	0.04%	248
2016 Q3	$1.47M	Buy	12,006 +257	+2%	+$33.1K	0.04%	260
2016 Q2	$1.37M	Buy	11,749 +187	+2%	+$26.5K	0.03%	251
2016 Q1	$1.61M	Buy	11,562 +1,035	+10%	+$152K	0.04%	238
2015 Q4	$2.01M	Sell	10,527 -2,412	-19%	-$421K	0.05%	183
2015 Q3	$2.02M	Buy	12,939 +263	+2%	+$48K	0.05%	204
2015 Q2	$2.29M	Buy	12,676 +691	+6%	+$119K	0.06%	180
2015 Q1	$2.08M	Buy	11,985 +301	+3%	+$54.5K	0.05%	191
2014 Q4	$2.16M	Buy	11,684 +3,742	+47%	+$693K	0.05%	179
2014 Q3	$1.32M	Buy	7,942 +561	+8%	+$92.1K	0.04%	180
2014 Q2	$1.15M	Sell	7,381 -805	-10%	-$127K	0.03%	179
2014 Q1	$1.25M	Buy	8,186 +863	+12%	+$137K	0.04%	174
2013 Q4	$973K	Sell	7,323 -21	-0.3%	-$2.52K	0.03%	195
2013 Q3	$853K	Buy	7,344 +585	+9%	+$64.2K	0.02%	202
2013 Q2	$623K	Buy	+6,759	New	+$651K	0.02%	222

Other funds holding ALXN

BCI

Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return

NICM

Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return

TAIM

TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return

CFO

CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return